Methylation profiling identified novel differentially methylated markers includingOPCMLandFLRT2in prostate cancer

The epigenetics of prostate cancer diagnosis and prognosis

(2015) Michael L. Blute et al.   CURRENT OPINION IN UROLOGY

Prognostic DNA Methylation Markers for Prostate Cancer

(2014) Siri Strand et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Transcriptional Activity of Heparan Sulfate Biosynthetic Machinery is Specifically Impaired in Benign Prostate Hyperplasia and Prostate Cancer

(2014) Anastasia V. Suhovskih et al.   Frontiers in Oncology

Methylation markers for prostate cancer prognosis: a systematic review

(2013) Chun Chao et al.   CANCER CAUSES & CONTROL

Genomic Profiling Defines Subtypes of Prostate Cancer with the Potential for Therapeutic Stratification

(2013) J. R. Schoenborn et al.   CLINICAL CANCER RESEARCH

Absolute Quantitation of DNA Methylation of 28 Candidate Genes in Prostate Cancer Using Pyrosequencing

(2013) Nataڑa Vasiljeviš et al.   DISEASE MARKERS

DNA Methylation Signatures for Prediction of Biochemical Recurrence After Radical Prostatectomy of Clinically Localized Prostate Cancer

(2013) Christa Haldrup et al.   JOURNAL OF CLINICAL ONCOLOGY

A Three-Marker FISH Panel Detects More Genetic Aberrations of AR, PTEN and TMPRSS2/ERG in Castration-Resistant or Metastatic Prostate Cancers than in Primary Prostate Tumors

(2013) Xiaoyu Qu et al.   PLoS One

Identification of novel DNA-methylated genes that correlate with human prostate cancer and high-grade prostatic intraepithelial neoplasia

(2013) J M Devaney et al.   PROSTATE CANCER AND PROSTATIC DISEASES

A novel four-color fluorescence in situ hybridization assay for the detection of TMPRSS2 and ERG rearrangements in prostate cancer

(2013) Xiaoyu Qu et al.   Cancer Genetics

Epigenetic biomarkers in prostate cancer: Current and future uses

(2012) Karen Chiam et al.   CANCER LETTERS

The OPCML Tumor Suppressor Functions as a Cell Surface Repressor–Adaptor, Negatively Regulating Receptor Tyrosine Kinases in Epithelial Ovarian Cancer

(2012) Arthur B. McKie et al.   Cancer Discovery

Mouse FLRT2 Interacts with the Extracellular and Intracellular Regions of FGFR2

(2011) K. Wei et al.   JOURNAL OF DENTAL RESEARCH

The role of FGF/Erk signaling in pluripotent cells

(2010) F. Lanner et al.   DEVELOPMENT

Epigenetic Alterations in Human Prostate Cancers

(2009) William G. Nelson et al.   ENDOCRINOLOGY

Gleason Score and Lethal Prostate Cancer: Does 3 + 4 = 4 + 3?

(2009) Jennifer R. Stark et al.   JOURNAL OF CLINICAL ONCOLOGY

Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts

(2009) Akiko Doi et al.   NATURE GENETICS

The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores

(2009) Rafael A Irizarry et al.   NATURE GENETICS

Aberrant methylation of the Adenomatous Polyposis Coli (APC) gene promoter is associated with the inflammatory breast cancer phenotype

(2008) I Van der Auwera et al.   BRITISH JOURNAL OF CANCER

Concepts of epigenetics in prostate cancer development

(2008) C S Cooper et al.   BRITISH JOURNAL OF CANCER

Management of Complications of Prostate Cancer Treatment

(2008) M. D. Michaelson et al.   CA-A CANCER JOURNAL FOR CLINICIANS

DNA Hypomethylation Arises Later in Prostate Cancer Progression than CpG Island Hypermethylation and Contributes to Metastatic Tumor Heterogeneity

(2008) Srinivasan Yegnasubramanian et al.   CANCER RESEARCH

The Iroquois Homeobox Gene 5 Is Regulated by 1,25-Dihydroxyvitamin D3 in Human Prostate Cancer and Regulates Apoptosis and the Cell Cycle in LNCaP Prostate Cancer Cells

(2008) A. Myrthue et al.   CLINICAL CANCER RESEARCH

Comprehensive high-throughput arrays for relative methylation (CHARM)

(2008) R. A. Irizarry et al.   GENOME RESEARCH

OPCML Is a Broad Tumor Suppressor for Multiple Carcinomas and Lymphomas with Frequently Epigenetic Inactivation

(2008) Yan Cui et al.   PLoS One